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Abstract: 
Black cumin (Nigella sativa) is a spice having medicinal properties with pungent and bitter 
odour. It is used since thousands of years to treat various ailments, including cancer mainly in 
South Asia and Middle Eastern regions. Substantial evidence in multiple research studies 
emphasizes about the therapeutic importance of bioactive principles of N. sativa in cancer 
bioassays; however, the exact mechanism of their anti-tumour action is still to be fully 
comprehended. The current study makes an attempt in this direction by exploiting the 
advancements in the Insilico reverse screening technology. In this study, three different 
Insilico Reverse Screening approaches have been employed for identifying the putative 
molecular targets of the bioactive principles in Black cumin (thymoquinone, alpha-hederin, 
dithymoquinone and thymohydroquinone) relevant to its anti-tumour functionality. The 
identified set of putative targets is further compared with the existing set of experimentally 
validated targets, so as to estimate the performance of insilico platforms. Subsequently, 
molecular docking simulations studies were performed to elucidate the molecular interactions 
between the bioactive compounds & their respective identified targets. The molecular 
interactions of one such target identified i.e. VEGF2 along with thymoquinone depicted one 
H-bond formed at the catalytic site. The molecular targets identified in this study need further 
confirmatory tests on cancer bioassays, in order to justify the research findings from Insilico 
platforms. This study has brought to light the effectiveness of usage of Insilico Reverse 
Screening protocols to characterise the un-identified target-ome of poly pharmacological 
bioactive agents in spices.  
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Introduction: 
Spices and medicinal herbs are known to have anti-cancer characteristics which can be used 
to target the tumor growth and further damage [1]. One such spice is Nigella sativa, also 
called as black cumin. The spice Nigella sativa belongs to Ranunculaceae family. It is an 
annual herb widely seen in India, Middle East, Europe, Greece and Egypt [2]. It is listed in 
the “Medicine of the Prophet” as a natural remedy to cure all pathological conditions. Its 
active ingredients are used from ancient times as Unani, Ayurveda, and Chinese medication 
for various diseases like asthma, rheumatoid arthritis, immune and inflammatory diseases [3]. 
The main active component of black cumin volatile oil is Thymoquinone (TQ), of about 54% 
and others include monoterpenes like p-cymene, dithymoquinone (TQ2), thymohydroquinone 
(THQ) and alpha-pinene [4]. The seeds are thought to contain active ingredients having anti-
tumor characteristics [5]. 
A number of theories have been postulated concerning the anti-tumour mechanism of action 
of black cumin and its bioactive ingredients against cancer. The first theory states that 
Thymoquinone, a principle component in Black cumin inhibits the DNA synthesis process 
leading to apoptosis and thereby hindering the cell proliferation. 5-fluorouracil inhibits 
thymidine synthesis and is seen to cure many forms of cancer. A number of studies have 
established that the pro-apoptotic mechanism of thymoquinone is mediated by both p53 
dependent pathways and p53 independent pathways. It is also observed that there is a 
substantial inhibition of Bcl-2 proteins, NF-kappa B, DNA methyl transferases, Histone 
deacetylase by thymoquinone [4].The second theory postulated that the anti-tumour effects of 
black cumin is because of its potent anti-inflammatory properties. This was established by a 
research study on thymoquinone on pancreatic cells, in which it was observed that this 
compound inhibits NF-κβ pathway leading to reduction in the growth of pancreatic cancer 
[6]. The third theory postulated that the anti-cancer effect of black cumin is because of its 
anti-angiogenic mechanism.  In this context, it was observed in invitro and invivo study that 
thymoquinone inhibits the AKT and EKT signalling pathways and depicts inhibitory action 
on key cancer regulatory proteins such as, VEGF, NF-κβ, c-Jun [7].  
The process of identification of molecular targets for the established small molecules utilizes 
a series of biochemical and quantitative proteomics protocols. These techniques are time 
consuming and protocols needs to be standardized. In recent times, an alternative approach 
named “Insilico Reverse Screening “has become very popular for the task of molecular target 
identification. This method utilizes a computational search strategy on a panel of 
chemogenomics- derived target database to derive a set of putative targets for a given small 
molecule [8]. This approach has been successfully employed to decipher the molecular 
targetability of active ingredients used in Ayurveda medicine [9]. Reverse pharmacophore 
mapping is based on alignment of the ligand to an available pharmacophore from a panel of 
pharmacophore database. Many such tools have been developed in the recent years. They 
include Tarfisdock [10], PharmMapper [11], ReverseScreen3D [12], idTarget [13], Target 
Hunter [14] and ChemMapper [15].  
In the current study, a unified approach integrating PharmMapper, ReverseScreen3D and 
TargetHunter to identify the potential targets for N.sativa bioactive ingredients. The targets 
prioritized were further validated for its anti-cancerous activity by matching up to 
experimental proven targets. Optimization is performed by studying the binding poses of 
these probable targets against the bioactive agents. 
Methodology: 
Identification of bioactive constituents of Black cumin by Literature review 
Black cumin has number of chemically diverse bioactive agents contributing to its anti-cancer 
functionality. Literature review revealed the principal bioactive components of black cumin 
i.e. Thymoquinone, alpha-hederin, dithymoquinone and thymohydroquinone. The structures 
of these molecules were retrieved from NCBI PubChem in sdf format.  
Reverse Screening approaches to identify potential therapeutic targets 
The reverse screening strategy in this study has been implemented using three insilico 
platforms namely, PharmMapper, ReverseScreen3D and TargetHunter. The sdf and .mol2 
formats of the bioactive constituents of N.sativa i.e. Thymoquinone, Alpha-hederin, 
Dithymoquinone and Thymohydroquinone were submitted to the three tools as an input. The 
PharmMapper gives the best mapping poses by comparing with available targets in 
PharmTargetDB and the respective N-best fit poses are generated. In ReverseScreen3d, for 
each target protein a single ligand that has highest similarity with 2D similarity of input 
molecule is generated, furthermore, a 3D similarity search is performed to match the ligands 
generated from the database with the input molecule. Target Hunter utilizes an algorithm for 
predicting the targets, namely the “Targets Associated with its MOst SImilar Counterparts to 
generate hits. The target list generated as output from the three tools was further annotated to 
screen out the possible target list having significant association to cancer. 
Retrieving experimentally validated target’s information from Bioassay databases 
The targets identified from the reverse screening approach were further validated for their 
anti-cancer properties experimental repositories including NCBI PubChem, NPACT [16] and 
Cancer Resource database [17]. 
Comparative analysis of identified putative targets with the experimental targets 
The potential targets identified from reverse screening approaches were compared with the 
experimental results to validate the results obtained from the inverse screening approaches. 
Classification of potential targets based on mode of action 
To understand the precise mechanistic behaviour of each bioactive agent, the identified 
targets were categorized into different functional classes: a) anti-proliferation b) anti-
apoptosis c) anti-inflammation d) anti-invasive. 
Molecular Docking studies of the potential targets with the bioactive components 
Docking studies were performed to depict the protein and the bioactive agent interactions 
using AutoDock PyRx4.2. The 3D structures of identified targets were retrieved from RCSB 
PDB and the structures of small molecules were retrieved from NCBI PubChem. These 
molecules along with targets were submitted to AutoDock PyRx4.2 to perform docking 
simulations. 
Validation of the docked poses 
To re-affirm the successful target identification in the current study, molecular docking 
studies was conducted on Crystallographic structure having bound ligand. The structure of 
Vascular Endothelial Growth Factor-2 (VEGF-2) was retrieved from RSCB-PDB (PDB ID: 
3CP9). The co-crystallized ligand was removed from the original structure and was re-
docked. 
Results and Discussion: 
The targets identified for thymoquinone from insilico techniques are depicted in Table 1. 
Anti-proliferative and Anti-apoptotic mechanisms in N.sativa 
The principle agents of N.sativa including Thymoquinone, Alpha-hederin and 
Dithymoquinone were found to have potent anti-proliferative and anti-apoptotic mechanisms. 
From the “set of putative targets” identified for Thymoquinone by Insilico Reverse Screening 
process,  it was observed that many of these identified targets Cyclin-A2, Cell division 
protein kinase 2, Dihydrofolate reductase, Deoxycytidine kinase, Caspase 3, Bcl-X, Heat 
shock protein HSP-90 alpha,  are significant contributor to the process of cell proliferation 
and apoptosis in cancer. Alpha-hederin also identified some prevalent targets including Ras 
related protein rap-2a, Cathepsin K, Estradiol 17-beta dehydrogenase-1, GTPase HRas, 
Cellular retinoic acid-binding protein 2, Dihydroorate dehydrogenase and many more.  
Anti-inflammatory mechanisms in N.sativa 
The anti-inflammatory potency of Nigella sativa is predominantly contributed by its principle 
ingredient Thymoquinone. Using the Insilico Reverse Screening protocol it was identified 
that the putative targets of thymoquinone responsible for its anti-inflammatory action are the 
following: Aldose reductase, Leukotriene A-4 hydrolase, inducible nitrogen oxide synthase 
(iNOS), and Glutathione-requiring prostaglandin D synthase. 
Anti-angiogenesis mechanism in N.sativa 
Using the Insilico Reverse Screening protocol it was identified that the putative targets of 
thymoquinone, alpha-hederin, dithymoquinone and thymohydroquinone responsible for its 
anti-angiogenic action  are  the following : VEGF, MMP-9, Macrophage metalloelastase, 
Stromelysin , Basic fibroblast growth factor. 
Molecular Docking analysis with VEGF 2 
VEGF is a cell signalling protein that initiates vasculogenesis and angiogenesis. It acts as 
supplier of oxygen during inadequate blood supply. Overexpression of VEGF expression 
leads to cancer followed by metastasis. The cellular response is mediated by binding to 
tyrosine kinase receptors called VEGFRs which dimerize and activate by trans 
phosphorylation. They are categorized as VEGFR-1, VEGFR-2 and VEGFR-3. It is seen that 
VEGF binding to VEGFR-2 domains 2 and 3 enhances the likelihood of other VEGFR-2 
binding. It forms a dimer and they are stabilized followed by auto phosphorylation leading to 
activation of extracellular receptor kinase (ERK) signalling pathway. 
VEGFR-2 tyrosine kinase domain has a dual 70 amino acid insert region for kinase. The 
dimer is formed when VEGF-A binds to VEGFR-2 followed by auto-phosphorylation   at 
insert kinase region and carboxy terminal tail [18]. VEGFR-2 (PDB ID: 3CP9) protein used 
in this study for molecular docking simulation has an inbound ligand 3-(2-aminoquinazolin-
6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one, referred as C19. It is an 
aminoquinazoline pyridine capable of inhibiting several targets like KDR, p38, Lck and Src 
[19]. The original crystallographic ligand was removed from the protein and re-docked to 
analyse the conformation difference of the ligand in pre-docking and post-docking poses. The 
pre-docked and post-docked poses were superimposed using PyMOL software. 
The pre-docked pose of the ligand with the VEGF-2 retrieved from PDBsum indicated that 
the bound ligand formed 3 hydrogen bonds: one bond with Asp1046 (A) and two bonds with 
Cys919 (A). The post-docked pose (Seen in Figure 1(b)) indicated that original ligand (C19) 
formed 4 hydrogen bonds: one bond with Ile1044 (A), Asp1046 (A) and two bonds with 
Cys919 (A). 
The H-bonds formed and RMSD (Root Mean Square Deviation) were calculated for the 
theoretical model as well as the experimental structure and it was observed that the H-bond 
length deviation between the crystal structure and docked pose was less than 0.20Å.The 
RMSD for C19 between the crystal structure and docked poses was 0.065Å. The results 
indicate ability of AutoDock simulations to replicate the experimental binding information of 
ligand-VEGF 2 complex. 
Binding pose of Thymoquinone with VEGF 2 
The post-docked binding conformation of thymoquinone with VEGF2 is illustrated in the 
Figure 1(b). It has a binding energy of -7.57 kcal/mol. The observations indicate that 
thymoquinone binds to VEGF-2 at the same catalytic site as that of the C19. Interaction of 
thymoquinone at the active site involves Leu840, Val848, Ala866, Val867, Glu885, Thr916, 
Leu1035, Cys1045 and Asp1046, which is analogous to the binding pattern of C19 at the 
catalytic site. Thymoquinone forms single N-H...O hydrogen bond with Asp1046 having 
bond length of 3.20Å. The similar hydrogen bond can be observed in the C19 with bond 
length of 3.08 Å. The interaction of thymoquinone is mainly hydrophobic. The docking 
cluster analysis of all runs showed a consistent interaction with Asp1046.  The interactions 
are studied via the electrostatic pattern and hydrogen bonds formed. The results indicate 
capacity of thymoquinone to act as a potent inhibitor of VEGF2 at its catalytic site. 
 
Conclusion: 
Many spices have traditionally been used in culinary and therapeutic applications by 
traditional practitioners without being aware of their precise mechanism of action. The 
current study is a true attempt to elucidate the exact poly pharmacological targetability of 
bioactive agents of black cumin. The putative target set identified by the “Insilico target 
fishing” approach in this study correlate well with the experimental findings.  The theories of 
the anti-cancer mechanism of bioactive agents of N. Sativa were further strengthened by the 
identification of targets from different categories including, anti-proliferative, anti-apoptosis, 
anti-inflammatory, and anti-angiogenic. Molecular docking studies of the “putative target set 
identified targets” with their respective bioactive compounds demonstrated their binding at 
the catalytic site of the protein targets, thereby proving their antagonistic mechanism. Further 
validation studies with VEGF-2 with thymoquinone demonstrated that the catalytic action is 
because of the inter-molecular H-bonds and other interactions. The “putative target set 
identified targets” has to be further validated in invivo and invitro bioassays to support the 
findings of this study. 
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Table 1: The primary targets of thymoquinone identified from reverse screening approaches 
PDB ID Protein Target Procedure of 
reverse 
screening 
Experimental 
Evidence 
Binding 
energy 
(kcal/mol) 
2FGI Basic fibroblast 
growth factor 
receptor 1 
PharmMapper/ 
ReverseScreen3D 
CancerResource -4.65 
1P62 Deoxycytidine 
kinase 
PharmMapper CancerResource -4.75 
2X0V Cellular tumor 
antigen p53 
ReverseScreen3D NPACT -4.6 
1DB1 Vitamin D3 
receptor 
PharmMapper/ 
ReverseScreen3D 
CancerResource -5.17 
1R9O Cytochrome 
P450 2CP 
PharmMapper/ 
ReverseScreen3D 
CancerResource -4.63 
 1E3G Androgen 
receptor 
PharmMapper/ 
ReverseScreen3D 
CancerResource -5.28 
2C6T Cyclin A2 PharmMapper CancerResource -4.77 
3BL1 Carbonic 
Anhydrase II 
PharmMapper/ 
ReverseScreen3D 
CancerResource -4.33 
1HFQ Dihydrofolate 
reductase 
PharmMapper/ 
ReverseScreen3D 
CancerResource Error 
3CP9 Vascular 
endothelial 
growth factor 2 
PharmMapper/ 
ReverseScreen3D 
CancerResource -7.57 
1B41 Acetylcholine 
esterase 
Target Hunter NCBI PubChem -4.09 
2QG0 Heat shock 
protein HSP-90 
alpha 
PharmMapper CancerResource -4.14 
3F7H Baculoviral IAP 
repeat-containing 
protein 7 
PharmMapper/ 
ReverseScreen3D 
CancerResource -3.73 
2FZ8 Aldose reductase PharmMapper/ 
ReverseScreen3D 
CancerResource -5.99 
1RW8 TGF-beta 
receptor type-1 
PharmMapper/ 
ReverseScreen3D 
CancerResource -5.21 
1GRE Glutathione 
reductase, 
mitochondrial 
PharmMapper CancerResource -4.65 
2R7B 3-
phosphoinositide-
dependent 
protein kinase 1 
 
PharmMapper/ 
ReverseScreen3D 
CancerResource -4.59 
1NME Caspase 3 ReverseScreen3D CancerResource -3.99 
1YSG Apoptosis 
regulator Bcl-X 
ReverseScreen3D NPACT -3.89 
3PXZ Cell division 
protein kinase 2 
PharmMapper, 
ReverseScreen3D 
CancerResource -5.21 
1GKC Matrix 
metalloprotease 9 
PharmMapper, 
ReverseScreen3D 
CancerResource -5.64 
2RG6 MAP kinase 14 PharmMapper, 
ReverseScreen3D 
CancerResource -4.81 
 Figure-1: (a) The molecular structures of bioactive agents of N.sativa namely, 
Thymoquinone and alpha-hederin; (b) The binding site of Thymoquinone and C19 to VEGF2 
depicted in microenvironment. Thymoquinone binds with a single H-bond with Asp1046, 
whereas in (c) the original ligand, C19 forms 4 hydrogen bonds with residues Asp1046, 
Ile1044 and two hydrogen bonds with Cys919 (green dotted lines); (d) The docked 
conformation of Thymoquinone and the original ligand, C19 with VEGF2 chain A. 
 
 
